SAN FRANCISCO--(BUSINESS WIRE)--
QuiO, a digital healthcare company providing smart injection devices and connected software for monitoring, engaging and supporting patients taking injectable therapies, has been named the inaugural Innovation Champion of the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health and life sciences organizations to tackle some of the world’s greatest healthcare challenges, including access, affordability and transparency. The award was announced at the StartUp Health Festival during the 35th Annual J.P. Morgan Healthcare Conference in San Francisco.
QuiO, based out of New York City, has developed a real-time, wireless injection device and cloud platform for connected drug delivery devices. The company’s Smartinjector device platform is a fully-connected drug deliver solution, enabling remote monitoring of dosing events and injection performance without syncing or smartphone required. It’s Health Insurance Portability and Accountability Act (HIPAA)-compliant software includes secure web dashboards for monitoring and supporting patient populations remotely.
As part of Accenture’s HealthTech Innovation Challenge, more than 500 startups from around the world demonstrated how their innovative technology and business models help improve the way people access and manage healthcare. Finalists presented to an exclusive panel of 29 judges, comprised of senior executives from globally recognized health and life sciences organizations. As well as gaining access to these industry-leading companies as they seek to bring their ideas to market, the start-ups gained an opportunity to participate in StartUp Health’s Launchpad program.
“Being named Top Innovator at the Accenture HealthTech Innovation Challenge is a great success for our team and validation for our medical device product and our company,” said Alexander Dahmani, chief executive officer and founder of QuiO. “The trust of the HealthTech Innovation Challenge judges lets us know we are on the right path to help lead the future of the healthcare industry.”
CaptureProof was recognized as a Top Innovator at the Accenture HealthTech Innovation Challenge. Based out of San Francisco, CaptureProof provides a medical camera that aims to mitigate HIPAA privacy risk by providing a visual narrative by putting photos, videos, chat and sensor data directly in the hands of patients and their doctors to better enable more efficient care, communications and collaboration to monitor progress, assess in historical health context and decide on optimal healthcare approach. Meghan Conroy, chief executive officer and founder of CaptureProof said, “This designation shows that healthcare is ripe for disruption, and we are excited to be changing the face of healthcare.”
UE Life Sciences, Inc., also captured the Top Innovator designation. UE Life Sciences, based out of Philadelphia, designs and develops point-of-care, easy-to-use and affordable cancer detection tools for use in the developing world. It has created the iBreastExam, an FDA-approved, hand-held, battery powered, wireless mHealth solution for early detection of breast lesions for use by public and private health agencies. Matthew Campisi, chief technology officer and cofounder of UE Life Sciences, said, “This is more than just this designation, it’s about the future of healthcare and the changing paradigm of how we think about treating patients.”
“I would like to congratulate QuiO for being named the inaugural Innovation Champion and to acknowledge all the start-ups that submitted to the Accenture HealthTech Innovation Challenge for their efforts to advance innovation in the industry,” said Anne O’Riordan, senior managing director of Accenture Life Sciences and co-author of Healthcare Disrupted. “The volume and quality of submissions are proof of the level of invention in healthcare, which can play a major role in improving the way people around the world can manage their health and associated costs. The Accenture HealthTech Innovation Challenge is a key part of our mission to improve the lives of individuals and provide better outcomes for healthcare providers.”
Brian Kalis, managing director of digital health at Accenture, said, “The excellence and diversity of submissions received from startups around the globe further demonstrate the momentum of digital innovation in healthcare. Accenture is proud to help the likes of [winning company], [Company B and Company C] infuse fresh ideas through programs such as the HealthTech Innovation Challenge. We look forward to working with these and other companies in the future, continuing our role in facilitating open innovation between a broad spectrum of stakeholders to help advance solutions to the healthcare industry’s toughest challenges.”
This Challenge from Accenture Health and Life Sciences is tied to Accenture Ventures, which identifies the most promising sources of innovation in the market. It uses an open innovation approach that involves working with start-ups, entrepreneurs, investors, academic R&D, and corporate R&D groups around the world. Accenture Ventures is a key element of the Accenture Innovation Architecture, which brings together the company’s capabilities — from research, ventures and labs to studios, innovation centers and delivery centers — to develop and deliver disruptive innovations for clients, and to scale them faster.
Accenture (ACN) is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations. Combining unmatched experience and specialized skills across more than 40 industries and all business functions – underpinned by the world’s largest delivery network – Accenture works at the intersection of business and technology to help clients improve their performance and create sustainable value for their stakeholders. With more than 394,000 people serving clients in more than 120 countries, Accenture drives innovation to improve the way the world works and lives. Visit us at www.accenture.com.
Accenture’s support of the selected companies will help them as they further develop their solutions and products. In supporting such initiatives, however, Accenture is in no way promoting or intending to market any one particular solution or product or otherwise offer or market a medical device or clinical solution. Each company uses its own operations to ensure compliance with applicable laws and regulations.